Carcinogenesis, Vol. 21, No. 7, 1281-1289,
July 2000
© 2000 Oxford University Press
Accelerated Paper |
The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer
1 Division of Environmental Health Sciences, Joseph L. Mailman School of Public Health, 60 Haven Ave, New York, NY 10032,
2 Department of Pathology and
3 Department of Surgery, Columbia Presbyterian Medical Center, New York, NY, USA
A number of polycyclic aromatic hydrocarbons (PAH) are widespread environmental contaminants that cause mammary cancer experimentally. We investigated whether exposure and susceptibility to PAH, as measured by PAH–DNA adducts in breast tissue, are associated with human breast cancer. We carried out a hospital-based case-control study using immunohistochemical methods to analyze PAH–DNA adducts in tumor and nontumor breast tissue from cases and benign breast tissue from controls. The subjects were white, African-American and Latina women without prior cancer or treatment, including 119 women with breast cancer and 108 with benign breast disease without atypia. PAH–DNA adducts measured in breast tumor tissue of 100 cases and in normal tissue from 105 controls were significantly associated with breast cancer (OR=4.43, 96% CI 1.09–18.01) after controlling for known breast cancer risk factors and current active and passive smoking, and dietary PAH. There was substantial interindividual (17-fold) variability in adducts overall, with 27% of cases and 13% of controls having elevated adducts. The odds ratio for elevated adducts in tumor tissue compared with control tissue was 2.56 (1.05–6.24), after controlling for potential confounders. Adduct levels in tumor tissue did not vary by stage or tumor size. Among 86 cases with paired tumor and nontumor tissue, adducts levels in these two tissues were highly correlated (r=0.56, P<0.001). However, the corresponding associations between case-control status and adducts measured in nontumor tissue from 90 cases and in normal tissue from 105 controls were positive but not statistically significant. Overall, neither active nor passive smoking, or dietary PAH were significantly associated with PAH–DNA adducts or breast cancer case-control status. These results suggest that genetic damage reflecting individual exposure and susceptibility to PAH may play a role in breast cancer; but more research is needed to determine whether the findings are relevant to causation or progression of breast cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Rohrmann, S.-U. Lukas Jung, J. Linseisen, and W. Pfau Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue Mutagenesis, March 1, 2009; 24(2): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Taioli Gene-environment interaction in tobacco-related cancers Carcinogenesis, August 1, 2008; 29(8): 1467 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Rybicki, C. Neslund-Dudas, C. H. Bock, A. Rundle, A. T. Savera, J. J. Yang, N. L. Nock, and D. Tang Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate and Biochemical Recurrence after Prostatectomy Clin. Cancer Res., February 1, 2008; 14(3): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Nock, D. Tang, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, K. G. Monaghan, A. Koprowski, N. Mitrache, J. J. Yang, et al. Associations between Smoking, Polymorphisms in Polycyclic Aromatic Hydrocarbon (PAH) Metabolism and Conjugation Genes and PAH-DNA Adducts in Prostate Tumors Differ by Race Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Burdick, I. D. Ivnitski-Steele, F. T. Lauer, and S. W. Burchiel PYK2 mediates anti-apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in mammary epithelial cells Carcinogenesis, November 1, 2006; 27(11): 2331 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Prince, C. T. Campbell, T. A. Robertson, A. J. Wells, and H. E. Kleiner Naturally occurring coumarins inhibit 7,12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland Carcinogenesis, June 1, 2006; 27(6): 1204 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Currier, S. E. Solomon, E. G. Demicco, D. L. F. Chang, M. Farago, H. Ying, I. Dominguez, G. E. Sonenshein, R. D. Cardiff, Z.-X. J. Xiao, et al. Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors Toxicol Pathol, October 1, 2005; 33(6): 726 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Rundle, P. Vineis, and H. Ahsan Design Options for Molecular Epidemiology Research within Cohort Studies Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1899 - 1907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Bonner, D. Han, J. Nie, P. Rogerson, J. E. Vena, P. Muti, M. Trevisan, S. B. Edge, and J. L. Freudenheim Breast Cancer Risk and Exposure in Early Life to Polycyclic Aromatic Hydrocarbons Using Total Suspended Particulates as a Proxy Measure Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Rybicki, A. Rundle, A. T. Savera, S. S. Sankey, and D. Tang Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate Cancer Cancer Res., December 15, 2004; 64(24): 8854 - 8859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Larsen, P. B. Brake, R. S. Pollenz, and C. R. Jefcoate Linked Expression of Ah Receptor, ARNT, CYP1A1, and CYP1B1 in Rat Mammary Epithelia, in Vitro, Is Each Substantially Elevated by Specific Extracellular Matrix Interactions that Precede Branching Morphogenesis Toxicol. Sci., November 1, 2004; 82(1): 46 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liang, X. Miao, Y. Zhou, W. Tan, and D. Lin A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking Carcinogenesis, May 1, 2004; 25(5): 773 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Kocabas, S. Sardas, S. Cholerton, A. K. Daly, and A. E. Karakaya N-Acetyltransferase (NAT2) Polymorphism and Breast Cancer Susceptibility: A Lack of Association in a Case-Control Study of Turkish Population International Journal of Toxicology, January 1, 2004; 23(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Foster, E. V. Younglai, O. Boutross-Tadross, C. L. Hughes, and M. G. Wade Mammary Gland Morphology in Sprague-Dawley Rats following Treatment with an Organochlorine Mixture in Utero and Neonatal Genistein Toxicol. Sci., January 1, 2004; 77(1): 91 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Burdick, J. W. Davis II, K. J. Liu, L. G. Hudson, H. Shi, M. L. Monske, and S. W. Burchiel Benzo(a)pyrene Quinones Increase Cell Proliferation, Generate Reactive Oxygen Species, and Transactivate the Epidermal Growth Factor Receptor in Breast Epithelial Cells Cancer Res., November 15, 2003; 63(22): 7825 - 7833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rundle, D. Tang, L. Mooney, S. Grumet, and F. Perera The Interaction between Alcohol Consumption and GSTM1 Genotype on Polycyclic Aromatic Hydrocarbon-DNA Adduct Levels in Breast Tissue Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 911 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rundle and S. Schwartz Issues in the Epidemiological Analysis and Interpretation of Intermediate Biomarkers Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 491 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Smith, M. S. Miller, K. K. Lohman, L.D. Case, and J. J. Hu DNA damage and breast cancer risk Carcinogenesis, May 1, 2003; 24(5): 883 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Faraglia, S. Y. Chen, M. D. Gammon, Y. Zhang, S. L. Teitelbaum, A. I. Neugut, H. Ahsan, G. C. Garbowski, H. Hibshoosh, D. Lin, et al. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke Carcinogenesis, April 1, 2003; 24(4): 719 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gammon and R. M. Santella Reply Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 75-A - 76. [Full Text] [PDF]
|
|
|
|
|
|
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Divi, F. A. Beland, P. P. Fu, L. S. Von Tungeln, B. Schoket, J. E. Camara, M. Ghei, N. Rothman, R. Sinha, and M. C. Poirier Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring Carcinogenesis, December 1, 2002; 23(12): 2043 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Terry and T. E. Rohan Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 953 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Gammon, R. M. Santella, A. I. Neugut, S. M. Eng, S. L. Teitelbaum, A. Paykin, B. Levin, M. B. Terry, T. L. Young, L. W. Wang, et al. Environmental Toxins and Breast Cancer on Long Island. I. Polycyclic Aromatic Hydrocarbon DNA Adducts Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.T. Simmons and C. J. Portier Toxicogenomics: the new frontier in risk analysis Carcinogenesis, June 1, 2002; 23(6): 903 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Firozi, M. L. Bondy, A. A. Sahin, P. Chang, F. Lukmanji, E. S. Singletary, M. M. Hassan, and D. Li Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer Carcinogenesis, February 1, 2002; 23(2): 301 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhao, R. Lewis, D. R. Gustafson, W.-Q. Wen, J. R. Cerhan, and W. Zheng No Apparent Association of GSTP1 A313G Polymorphism with Breast Cancer Risk among Postmenopausal Iowa Women Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1301 - 1302. [Full Text] [PDF]
|
|
|
|
|
|
P. Xiong, M. L. Bondy, D. Li, H. Shen, L.-E Wang, S. E. Singletary, M. R. Spitz, and Q. Wei Sensitivity to Benzo(a)pyrene Diol-Epoxide Associated with Risk of Breast Cancer in Young Women and Modulation by Glutathione S-Transferase Polymorphisms: A Case-Control Study Cancer Res., December 1, 2001; 61(23): 8465 - 8469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C Johnson, J M Dixon, and C M Steel Risk factors for breast cancer BMJ, February 10, 2001; 322(7282): 365 - 365. [Full Text]
|
|
|
|
|
|
A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085. [Abstract] [Full Text]
|
|